Trial intelligence / Profile preview

Capecitabine maintenance in metastatic colorectal cancer

NCT02027363Phase 2Unknown

Sponsor
Sun Yat-sen University
Start
Jan 2010
Primary completion
Dec 2013
Countries
1
01

Overview

A Phase 2 trial of capecitabine in colorectal cancer (CRC), sponsored by Sun Yat-sen University. Status: unknown.

02

Drugs

capecitabine
03

Conditions

colorectal cancer (CRC)

Beyond the preview

Go deeper on NCT02027363.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02027363.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call